Search Tag: biotech
2023 02 May
Dimension Inx, a biomaterials platform company developing therapeutics that restore tissue and organ function, announced the appointments of Paul K. Wotton, Ph.D., to the board of directors and Chris Ehrlich as Senior Advisor. Dr. Wotton fills the role of Independent Director of the Board, created following Dimension's Series A raise of $15M...Read more
2022 21 Oct
Global experts continue to join SK bioscience, while its U.S. corporate entity is being established Company plans to strategically invest in personnel, innovation & infrastructure to ensure global competitiveness SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across...Read more
2022 21 Sep
Cambrian BioPharma , a multi-asset longevity biotech announces the appointment of Ruth Thieroff-Ekerdt, M.D., as Executive Vice President of Clinical Development. Her role became effective as of September 7th, 2022. Dr. Thieroff-Ekerdt joins Cambrian with 30+ years of global experience in pharmaceutical and biotech organizations of all sizes and...Read more
2022 07 Jul
Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX’s Board of Directors as Non-Executive Director, bringing nearly 30 years of global drug development experience Past achievements include approval of Augmentin BID for adults and children, plus foundational clinical development of breakthrough cancer immunotherapy checkpoint inhibitors, Yervoy...Read more
2022 21 Jan
Thermo Fisher Scientific, Inc. has completed its acquisition of Wilmington-based global contract research organization PPD. The $17.4 billion deal was finalized in December. Thermo Fisher – which supports life sciences research by helping customers solve complex analytical challenges, improve patient diagnostics and therapies or increase the productivity...Read more
2019 22 May
The level of sophistication used in due diligence should be on par with the level of complexity in a given industry. AI-Pharma companies are 100 times as complex as FinTech companies. Methodologies used to assess them should be 100 times as rigorous. Discovering new drugs using AI is one of the most challenging areas in biological...Read more
2016 27 Feb
Stockholm is cranking up the volume when it comes to life science opportunities. For healthcare, for the life science industry and for researchers. But most importantly – for you and me as future or current care recipients. The city is currently in the process of transforming a former railway depot into a flourishing life science arena. The area...Read more